|
FZD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.74311734122557E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.46713760532202E-12 |
| Normal-vs-Stage2 |
1.663480E-03 |
| Normal-vs-Stage3 |
4.588700E-04 |
| Normal-vs-Stage4 |
9.261300E-03 |
| Stage1-vs-Stage2 |
3.148600E-01 |
| Stage1-vs-Stage3 |
6.756000E-03 |
| Stage1-vs-Stage4 |
1.639620E-02 |
| Stage2-vs-Stage3 |
3.958600E-01 |
| Stage2-vs-Stage4 |
3.373400E-01 |
| Stage3-vs-Stage4 |
7.908200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.52065035510896E-12 |
| Normal-vs-AfricanAmerican |
2.109600E-02 |
| Normal-vs-Asian |
3.447400E-01 |
| Caucasian-vs-AfricanAmerican |
4.682200E-02 |
| Caucasian-vs-Asian |
5.132400E-01 |
| AfricanAmerican-vs-Asian |
9.903800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.86759999998287E-06 |
| Normal-vs-Female |
3.76143560743003E-13 |
| Male-vs-Female |
2.71230000004063E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.355000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.67420000085627E-09 |
| Normal-vs-Age(61-80Yrs) |
2.12959999634776E-08 |
| Normal-vs-Age(81-100Yrs) |
2.595200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.595700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.282000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.567800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.983200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.281600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.496040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.210400E-02 |
| Normal-vs-Grade 2 |
6.99285074290401E-12 |
| Normal-vs-Grade 3 |
3.47930000366148E-08 |
| Normal-vs-Grade 4 |
3.198000E-01 |
| Grade 1-vs-Grade 2 |
2.923200E-01 |
| Grade 1-vs-Grade 3 |
1.221210E-01 |
| Grade 1-vs-Grade 4 |
3.945900E-02 |
| Grade 2-vs-Grade 3 |
1.846050E-01 |
| Grade 2-vs-Grade 4 |
3.251400000015E-06 |
| Grade 3-vs-Grade 4 |
6.977100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
2.346000E-01 |
| ccA subtype-vs-ccB subtype |
1.62470037423645E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.96640004279658E-09 |
| Normal-vs-N1 |
8.299400E-01 |
| N0-vs-N1 |
7.784000E-02 |
|
|
